Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ADAM F BINDER

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1528389178
CMS profile
1260210
Location
PHILADELPHIA, PA

General Payments · PY2018–2024

$119,914.82

  • Reported across 81 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$32,231.87

22 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Karyopharm Therapeutics Inc. $18,062.31 11
Janssen Biotech, Inc. $13,510.56 10
GENZYME CORPORATION $659.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,144.91 3
PY2019 $3,703.00 1
PY2020 $2,020.00 1
PY2021 $7,152.50 5
PY2022 $34,235.55 22
PY2023 $39,426.99 27
PY2024 $32,231.87 22

Payment records · PY2024 (22)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
GENZYME CORPORATION $659.00 02/01/2024 Consulting Fee Undisputed 01/23/2026 1139817183 CMS
Janssen Biotech, Inc. $74.99 06/24/2024 Education Undisputed 01/23/2026 1078585001 CMS
Janssen Biotech, Inc. $100.80 07/09/2024 Food and Beverage Undisputed 01/23/2026 1078589201 CMS
Janssen Biotech, Inc. $3,575.00 07/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1078581572 CMS
Janssen Biotech, Inc. $1,100.00 10/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1078585869 CMS
Janssen Biotech, Inc. $125.00 10/22/2024 Food and Beverage Undisputed 01/23/2026 1078585954 CMS
Janssen Biotech, Inc. $3,575.00 10/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1078587166 CMS
Janssen Biotech, Inc. $144.78 11/04/2024 Travel and Lodging Undisputed 01/23/2026 1078583874 CMS
Janssen Biotech, Inc. $1,100.00 11/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1078587306 CMS
Janssen Biotech, Inc. $139.99 12/17/2024 Food and Beverage Undisputed 01/23/2026 1078583086 CMS
Janssen Biotech, Inc. $3,575.00 12/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1078585919 CMS
Karyopharm Therapeutics Inc. $2,037.50 03/21/2024 Honoraria Undisputed 01/23/2026 1145527519 CMS
Karyopharm Therapeutics Inc. $4,075.00 05/23/2024 Honoraria Undisputed 01/23/2026 1145527515 CMS
Karyopharm Therapeutics Inc. $8.27 05/23/2024 Food and Beverage Undisputed 01/23/2026 1145527523 CMS
Karyopharm Therapeutics Inc. $69.41 05/23/2024 Travel and Lodging Undisputed 01/23/2026 1145527525 CMS
Karyopharm Therapeutics Inc. $35.99 05/23/2024 Travel and Lodging Undisputed 01/23/2026 1145527529 CMS
Karyopharm Therapeutics Inc. $4,075.00 06/25/2024 Honoraria Undisputed 01/23/2026 1145527517 CMS
Karyopharm Therapeutics Inc. $12.41 06/25/2024 Food and Beverage Undisputed 01/23/2026 1145527521 CMS
Karyopharm Therapeutics Inc. $2,037.50 07/31/2024 Honoraria Undisputed 01/23/2026 1145527527 CMS
Karyopharm Therapeutics Inc. $1,630.00 10/17/2024 Honoraria Undisputed 01/23/2026 1145527535 CMS
Karyopharm Therapeutics Inc. $4,075.00 12/12/2024 Honoraria Undisputed 01/23/2026 1145527531 CMS
Karyopharm Therapeutics Inc. $6.23 12/12/2024 Food and Beverage Undisputed 01/23/2026 1145527533 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.